Parkinson's disease with late pick's dementia

Movement Disorders

Volumn 16, Issue 2, 2001, Pages 311-319

  Henderson, Jasmine M ^a   Gai, Wie Ping ^b   Hely, Mariese A ^c   Reid, Wayne G J ^d   Walker, Grant L ^e   Halliday, Glenda M ^a  

^a Prince os Wales Private Hospital   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d PRINCE OF WALES HOSPITAL   (Australia)

^e Westmead Neurological Centre   (Australia)

Author keywords

Alpha synuclein; Lewy bodies; Pick bodies; Tau

Indexed keywords

ANTIINFLAMMATORY AGENT; BENZATROPINE; CARBIDOPA; CHOLINERGIC RECEPTOR BLOCKING AGENT; LEVODOPA;

ADULT; ANAMNESIS; ARTHRITIS; ARTICLE; AUTOPSY; BEHAVIOR DISORDER; BRADYKINESIA; CASE REPORT; CHROMOSOME 17; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; DEATH; DETERIORATION; DISEASE SEVERITY; FAMILIAL DISEASE; FAMILY HISTORY; FEMALE; FRONTOTEMPORAL DEMENTIA; GENETIC DISORDER; HUMAN; IDIOPATHIC DISEASE; LEWY BODY; MEDICAL LITERATURE; MUSCLE RIGIDITY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PARKINSONISM; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; TREMOR;

ACTIVITIES OF DAILY LIVING; AGE FACTORS; APHASIA; ATROPHY; BRAIN; COGNITION DISORDERS; DISABILITY EVALUATION; FATAL OUTCOME; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LEWY BODIES; MENTAL DISORDERS; MIDDLE AGED; NERVE TISSUE PROTEINS; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PICK DISEASE OF THE BRAIN; REACTION TIME; SEVERITY OF ILLNESS INDEX; SYNUCLEINS; TAU PROTEINS;

EID: 0035297127     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.1053     Document Type: Article

References (45)

1. Cummings JL. Intellectual impairment in Parkinson's disease: clinical, pathologic and biochemical indices. J Geriatr Psychiatr Neurol 1988;1:24-36.
2. Mayeux R, Stern Y, Rosenstein R, et al. An estimate of the prevalence of dementia in idiopathic Parkinson's disease. Arch Neurol 1988;45:260-262.
3. Biggins CA, Boyd JL, Harrop FM, et al. A controlled, longitudinal study of dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 1992;55:566-571.
4. Ebmeier KP, Calder SA, Crawford JR, et al. Dementia in idiopathic Parkinson's disease: prevalence and relationship with symptoms and signs of Parkinsonism. Psychol Med 1991;21:69-76.
5. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson's disease. Arch Neurol 1999;56:33-39.
6. Hurtig H, Trojanowski J, Galvin J, et al. Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology 2000;54:1916-1921.
7. Mirra S, Heyman A, McKeel D, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
8. Hughes AJ, Daniel SE, Lees AJ. The clinical features of Parkinson's disease in 100 histologically proven cases. In: Narabayashi H, Nagatsu T, Yanagisawa N, Mizuno Y, eds. Advances in Neurology New York: Raven Press, Ltd., 1993:595-599.
9. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
10. Esiri MM, McShane RH. Parkinson's disease and dementia. In: Esiri MM, Morris JH, eds. The Neuropathology of Dementia. Cambridge: Cambridge University Press, 1997:174-193.
11. Daniel S. Parkinson's disease. In: Cruz-Sánchez FF, Ravid R, Cuzner ML, eds. Neuropathological Diagnostic Criteria for Brain Banking. Amsterdam: IOS Press, 1994:72-79.
12. Miller BL, Ikonte BS, Ponton M, et al. A study of the Lund-Manchester research criteria for frontotemporal dementia; Clinical and single-photon emission CT correlations. Neurology 1997;48: 937-942.
13. Hely MA, Morris JGL, Reid WGJ, et al. The Sydney Multicentre Study of Parkinson's disease: a randomized, prospective five year study comparing low dose bromocriptine with low dose levodopacarbidopa. J Neurol Neurosurg Psychiatry 1994;57:903-910.
14. Litvan I, Campbell G, Mangone CA, et al. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. Brain 1997;120:65-74.
15. Hely MA, Morris JGL, Rail D, et al. The Sydney multicentre study of Parkinson's disease: a report on the first 3 years. J Neurol Neurosurg Psychiatry 1989;52:324-328.
16. Hely MA, Morris JGL, Traficante R, et al. The Sydney Multicentre Study of Parkinson's disease: progression and mortality at 10 years. J Neurol Neurosurg Psychiatry 1999;67:300-307.
17. Reid WGJ, Broe GA, Hely MA, et al. The neuropsychology of de novo patients with idiopathic Parkinson's disease: the effects of age of onset. Int J Neurosci 1989;48:205-217.
18. Reid WGJ, Hely MA, Morris JGL, et al. A longitudinal study of Parkinson's disease: clinical and neuropsychological correlates of dementia. J Clin Neurosci 1996;3:327-333.
19. Hughes CP, Berg L, Danzinger WL, Cohen LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140:566-572.
20. Kertesz A, Davidson W, Fox H. Frontal Behavioural Inventory: diagnostic criteria for frontal lobe dementia. Can J Neurol Sci 1997;24:29-36.
21. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration. A consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
22. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
23. Constantinidis J, Richard J, Tissot R, Pick's disease. Eur Neurol 1974;11:208-217.
24. Foster NL, Wilhelmson K, Sima A, et al. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Ann Neurol 1997;41:706-715.
25. Hauw J, Daniel S, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994;44:2015-2019.
26. Gai WP, Power JHT, Blumbergs PC, Culvenor JG, Jensen PH. Alpha synuclein immunoisolation of glial inclusions from multiple system atrophy brain tissue reveals multiprotein components. J Neurochem 1999;73:2093-2100.
27. Hardman CD, McRitchie DA, Halliday GM, Morris JGL. The subthalamic nucleus in Parkinson's disease and progressive supranuclear palsy. J Neuropathol Exp Neurol 1997;56:132-142.
28. Forno LS, Eng LF, Selkoe DJ. Pick bodies in the locus coeruleus. Acta Neuropathol 1989;79:10-17.
29. Reid WGJ. The evolution of dementia in idiopathic Parkinson's disease: neuropsychological and clinical evidence in support of subtypes. Int Psychogeriatr 1992;4(Suppl. 2):147-160.
30. Taylor AE, Saint-Cyr JA. The neuropsychology of Parkinson's disease. Brain Cogn 1995;28:281-296.
31. Monza D, Soliveri P, Radice D, et al. Cognitive dysfunction and impaired organization of complex motility in degenerative parkinsonian syndromes. Arch Neurol 1998;55:372-378.
32. Geldmacher DS, Whitehouse PJ. Differential diagnosis of Alzheimer's disease. Neurology 1997;48:S2-S9.
33. Spillantini MG, Bird T, Ghetti B. Frontotemporal dementia and parkinsonism linked to chromosome 17: a new group of tauopathies. Brain Pathol 1998;8:387-402.
34. van Sweiten JC, Stevens M, Rosso SM, et al. Phenotypic variation in hereditary frontotemporal dementia with tau mutations. Ann Neurol 1999;46:617-626.
35. Mizutani T, Inose T, Nakajima S, et al. Familial parkinsonisn and dementia with ballooned neurons, agyrophilic neuronal inclusions, atypical neurofibrillary tangles, tau-negative astrocytic fibrillary tangles, and Lewy bodies. Acta Neuropathol 1998;95:15-27.
36. Dickson DW. Pick's disease: a modern approach. Brain Pathol 1998;8:339-354.
37. Murayama S, Mori H, Ihara Y, Tomonaga M. Immunocytochemical and ultrastructural studies of Pick's disease. Ann Neurol 1990;27:394-405.
38. Armstrong RA, Cairns NJ, Lantos PL. A comparison of histological and immunohistochemical methods for quantifying the pathological lesions of Pick's disease. Neuropathotogy 1998;18:295-300.
39. Takaushi S, Yamauchi S, Morimura Y, et al. Coexistence of Pick bodies and atypical Lewy bodies in the locus coeruleus neurons of Pick's disease. Acta Neuropathol 1995;90:93-100.
40. Pogacar S, Rubio A. Morphological features of Pick's and atypical Alzheimer's disease in Down's syndrome. Acta Neuropathol 1982;58:249-254.
41. Smith DA, Lantos PL. A case of combined Pick's disease and Alzheimer's disease. J Neurol Neurosurg Psychiatry 1983;46.
42. Hof PR, Bouras C, Perl DP, Morrison JH. Quantitative neuropathologic analysis of Pick's disease cases: cortical distribution of Pick bodies and coexistance with Alzheimer's disease. Acta Neuropathol 1994;87:115-124.
43. Kosaka K, Oyanagi S, Matsushita M, Hori A. Presenile dementia with Alzheimer-, Pick- and Lewy-body changes. Acta Neuropathol 1976;36:221-233.
44. Pasquier F, Delacourte A. Non-Alzheimer degenerative dementias. Curr Opin Neurol 1998;11:417-427.
45. Morris HR, Lees AJ, Wood NW. Neurofibrillary tangle parkinsonian disorders-Tau pathology and Tau genetics. Mov Disord 1999;14:731-736.